Abstract
Schizophrenia is a complex neuropsychiatric disorder with both neurochemical and neurodevelopmental components in the pathogenesis. Growing pieces of evidence indicate that schizophrenia has pathological components that can be attributable to the abnormalities of mitochondrial function, which is supported by the recent finding suggesting mitochondrial roles for Disrupted-in-Schizophrenia 1 (DISC1). In this minireview, we briefly summarize the current understanding of the molecular links between mitochondrial dysfunctions and the pathogenesis of schizophrenia, covering recent findings from human genetics, functional genomics, proteomics, and molecular and cell biological approaches.
Similar content being viewed by others
References
Akyol, O., Yanik, M., Elyas, H., Namli, M., Canatan, H., Akin, H., Yuce, H., Yilmaz, H.R., Tutkun, H., Sogut, S., et al. (2005). Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 123–131.
Altar, C.A., Jurata, L.W., Charles, V., Lemire, A., Liu, P., Bukhman, Y., Young, T.A., Bullard, J., Yokoe, H., Webster, M.J., et al. (2005). Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts. Biol. Psychiatry 58, 85–96.
American Psychiatric Association (2000). Diagnostic criteria from DSM-IV-TR (Washington, D.C., American Psychiatric Association).
Arion, D., Unger, T., Lewis, D.A., Levitt, P., and Mirnics, K. (2007). Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol. Psychiatry 62, 711–721.
Bae, Y.S., Oh, H., Rhee, S.G., and Yoo, Y.D. (2011). Regulation of reactive oxygen species generation in cell signaling. Mol. Cells 32, 491–509.
Ben-Shachar, D., and Laifenfeld, D. (2004). Mitochondria, synaptic plasticity, and schizophrenia. Int. Rev. Neurobiol. 59, 273–296.
Ben-Shachar, D., and Karry, R. (2008). Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 3, e3676.
Ben-Shachar, D., Bonne, O., Chisin, R., Klein, E., Lester, H., Aharon-Peretz, J., Yona, I., and Freedman, N. (2007). Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 807–813.
Ben-Shachar, D., Nadri, C., Karry, R., and Agam, G. (2009). Mitochondrial complex I subunits are altered in rats with neonatal ventral hippocampal damage but not in rats exposed to oxygen restriction at neonatal age. J. Mol. Neurosci. 38, 143–151.
Blass, J.P. (2002). Glucose/mitochondria in neurological conditions. Int. Rev. Neurobiol. 51, 325–376.
Brandon, N.J., Schurov, I., Camargo, L.M., Handford, E.J., Duran-Jimeniz, B., Hunt, P., Millar, J.K., Porteous, D.J., Shearman, M.S., and Whiting, P.J. (2005). Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site. Mol. Cell. Neurosci. 28, 613–624.
Brandon, N.J., Millar, J.K., Korth, C., Sive, H., Singh, K.K., and Sawa, A. (2009). Understanding the role of DISC1 in psychiatric disease and during normal development. J. Neurosci. 29, 12768–12775.
Brenner-Lavie, H., Klein, E., Zuk, R., Gazawi, H., Ljubuncic, P., and Ben-Shachar, D. (2008). Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia. Biochim. Biophys. Acta 1777, 173–185.
Brenner-Lavie, H., Klein, E., and Ben-Shachar, D. (2009). Mitochondrial complex I as a novel target for intraneuronal DA: modulation of respiration in intact cells. Biochem. Pharmacol. 78, 85–95.
Burdick, K.E., Kamiya, A., Hodgkinson, C.A., Lencz, T., DeRosse, P., Ishizuka, K., Elashvili, S., Arai, H., Goldman, D., Sawa, A., et al. (2008). Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epistasis and competitive binding. Hum. Mol. Genet. 17, 2462–2473.
Chan, D.C. (2006). Mitochondria: dynamic organelles in disease, aging, and development. Cell 125, 1241–1252.
Chubb, J.E., Bradshaw, N.J., Soares, D.C., Porteous, D.J., and Millar, J.K. (2008). The DISC locus in psychiatric illness. Mol. Psychiatry 13, 36–64.
Doi, N., Hoshi, Y., Itokawa, M., Usui, C., Yoshikawa, T., and Tachikawa, H. (2009). Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. PLoS One 4, e7799.
Eyles, D., Almeras, L., Benech, P., Patatian, A., Mackay-Sim, A., McGrath, J., and Feron, F. (2007). Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J. Steroid Biochem. Mol. Biol. 103, 538–545.
Frey, B.N., Valvassori, S.S., Gomes, K.M., Martins, M.R., Dal-Pizzol, F., Kapczinski, F., and Quevedo, J. (2006). Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res. 1097, 224–229.
Hall, M.H., Rijsdijk, F., Picchioni, M., Schulze, K., Ettinger, U., Toulopoulou, T., Bramon, E., Murray, R.M., and Sham, P. (2007). Substantial shared genetic influences on schizophrenia and event-related potentials. Am. J. Psychiatry 164, 804–812.
Horvath, S., Janka, Z., and Mirnics, K. (2011). Analyzing schizophrenia by DNA microarrays. Biol. Psychiatry 69, 157–162.
Iwamoto, K., Bundo, M., and Kato, T. (2005). Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by largescale DNA microarray analysis. Hum. Mol. Genet. 14, 241–253.
Iwazaki, T., McGregor, I.S., and Matsumoto, I. (2008). Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci. Lett. 435, 113–119.
Ji, B., La, Y., Gao, L., Zhu, H., Tian, N., Zhang, M., Yang, Y., Zhao, X., Tang, R., Ma, G., et al. (2009). A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications. J. Proteome Res. 8, 3633–3641.
Karry, R., Klein, E., and Ben Shachar, D. (2004). Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol. Psychiatry 55, 676–684.
Klushnik, T.P., Spunde, A., Yakovlev, A.G., Khuchua, Z.A., Saks, V.A., and Vartanyan, M.E. (1991). Intracellular alterations of the creatine kinase isoforms in brains of schizophrenic patients. Mol. Chem. Neuropathol. 15, 271–280.
Kolomeets, N.S., and Uranova, N.A. (1997). [Synaptic contacts in schizophrenia: study with immunocytochemical identification of dopaminergic neurons]. Zh. Nevrol. Psikhiatr. Im. S S Korsakova 97, 39–43.
Kolomeets, N.S., and Uranova, N. (2010). Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: a postortem morphometric study. World J. Biol. Psychiatry 11, 282–292.
Konradi, C., Sillivan, S.E., and Clay, H.B. (2012). Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol. Dis. 45, 37–47.
Kung, L., and Roberts, R.C. (1999). Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse 31, 67–75.
Malaspina, D., Friedman, J.H., Kaufmann, C., Bruder, G., Amador, X., Strauss, D., Clark, S., Yale, S., Lukens, E., Thorning, H., et al. (1998). Psychobiological heterogeneity of familial and sporadic schizophrenia. Biol. Psychiatry 43, 489–496.
Mao, Y., Ge, X., Frank, C.L., Madison, J.M., Koehler, A.N., Doud, M.K., Tassa, C., Berry, E.M., Soda, T., Singh, K.K., et al. (2009). Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 136, 1017–1031.
Martorell, L., Segues, T., Folch, G., Valero, J., Joven, J., Labad, A., and Vilella, E. (2006). New variants in the mitochondrial genomes of schizophrenic patients. Eur. J. Hum. Genet. 14, 520–528.
Mattson, M.P., Gleichmann, M., and Cheng, A. (2008). Mitochondria in neuroplasticity and neurological disorders. Neuron 60, 748–766.
Maurer, I., Zierz, S., and Moller, H. (2001). Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr. Res. 48, 125–136.
Middleton, F.A., Mirnics, K., Pierri, J.N., Lewis, D.A., and Levitt, P. (2002). Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 2718–2729.
Millar, J.K., Wilson-Annan, J.C., Anderson, S., Christie, S., Taylor, M.S., Semple, C.A., Devon, R.S., St Clair, D.M., Muir, W.J., Blackwood, D.H., et al. (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415–1423.
Millar, J.K., Christie, S., and Porteous, D.J. (2003). Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem. Biophys. Res. Commun. 311, 1019–1025.
Millar, J.K., James, R., Christie, S., and Porteous, D.J. (2005a). Disrupted in schizophrenia 1 (DISC1): subcellular targeting and induction of ring mitochondria. Mol. Cell. Neurosci. 30, 477–484.
Millar, J.K., Pickard, B.S., Mackie, S., James, R., Christie, S., Buchanan, S.R., Malloy, M.P., Chubb, J.E., Huston, E., Baillie, G.S., et al. (2005b). DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310, 1187–1191.
Mirnics, K., Middleton, F.A., Marquez, A., Lewis, D.A., and Levitt, P. (2000). Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53–67.
Mun, J.Y., Lee, T.H., Kim, J.H., Yoo, B.H., Bahk, Y.Y., Koo, H.S., and Han, S.S. (2010). Caenorhabditis elegans mitofilin homologs control the morphology of mitochondrial cristae and influence reproduction and physiology. J. Cell Physiol. 224, 748–756.
Munakata, K., Iwamoto, K., Bundo, M., and Kato, T. (2005). Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57, 525–532.
Park, Y.U., Jeong, J., Lee, H., Mun, J.Y., Kim, J.H., Lee, J.S., Nguyen, M.D., Han, S.S., Suh, P.G., and Park, S.K. (2010). Disrupted-in-schizophrenia 1 (DISC1) plays essential roles in mitochondria in collaboration with Mitofilin. Proc. Natl. Acad. Sci. USA 107, 17785–17790.
Prabakaran, S., Swatton, J.E., Ryan, M.M., Huffaker, S.J., Huang, J.T., Griffin, J.L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K.S., et al. (2004). Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9, 684–697, 643.
Prayson, R.A., and Wang, N. (1998). Mitochondrial myopathy, ence-phalopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome: an autopsy report. Arch. Pathol. Lab. Med. 122, 978–981.
Regenold, W.T., Phatak, P., Marano, C.M., Sassan, A., Conley, R.R., and Kling, M.A. (2009). Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol. Psychiatry 65, 489–494.
Rollins, B., Martin, M.V., Sequeira, P.A., Moon, E.A., Morgan, L.Z., Watson, S.J., Schatzberg, A., Akil, H., Myers, R.M., Jones, E.G., et al. (2009). Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One 4, e4913.
Rosenfeld, M., Brenner-Lavie, H., Ari, S.G., Kavushansky, A., and Ben-Shachar, D. (2011). Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol. Psychiatry 69, 980–988.
Rossi, M.N., Carbone, M., Mostocotto, C., Mancone, C., Tripodi, M., Maione, R., and Amati, P. (2009). Mitochondrial localization of PARP-1 requires interaction with mitofilin and is involved in the maintenance of mitochondrial DNA integrity. J. Biol. Chem. 284, 31616–31624.
Seybolt, S.E. (2010). Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia? Med. Hypotheses 75, 572–575.
Shao, L., Martin, M.V., Watson, S.J., Schatzberg, A., Akil, H., Myers, R.M., Jones, E.G., Bunney, W.E., and Vawter, M.P. (2008). Mito-chondrial involvement in psychiatric disorders. Ann. Med. 40, 281–295.
Somerville, S.M., Lahti, A.C., Conley, R.R., and Roberts, R.C. (2011). Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse 65, 215–224.
Stephan, K.E., Friston, K.J., and Frith, C.D. (2009). Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull. 35, 509–527.
Suzuki, T., Koizumi, J., Shiraishi, H., Ishikawa, N., Ofuku, K., Sasaki, M., Hori, T., Ohkoshi, N., and Anno, I. (1990). Mitochondrial encephalomyopathy (MELAS) with mental disorder. CT, MRI and SPECT findings. Neuroradiology 32, 74–76.
Swerdlow, R.H., Binder, D., and Parker, W.D. (1999). Risk factors for schizophrenia. N Engl. J. Med. 341, 371–372; author reply 372.
Treasaden, I.H., and Puri, B.K. (2008). Cerebral spectroscopic and oxidative stress studies in patients with schizophrenia who have dangerously violently offended. BMC Psychiatry 8Suppl 1, S7.
Ueno, H., Nishigaki, Y., Kong, Q.P., Fuku, N., Kojima, S., Iwata, N., Ozaki, N., and Tanaka, M. (2009). Analysis of mitochondrial DNA variants in Japanese patients with schizophrenia. Mitochondrion 9, 385–393.
Uranova, N.A. (1988). Structural changes in the neuropil of the frontal cortex in schizophrenia. Zh. Nevropatol. Psikhiatr. Im. S S Korsakova 88, 52–58.
Uranova, N.A., Orlovskaia, D.D., Vikhreva, O.V., Zimina, I.S., and Rakhmanova, V.I. (2001). Morphometric study of ultrastructural changes in oligodendroglial cells in the postmortem brain in endogenous psychoses. Vestn. Ross. Akad. Med. Nauk 42–48.
Uranova, N., Bonartsev, P., Brusov, O., Morozova, M., Rachmanova, V., and Orlovskaya, D. (2007). The ultrastructure of lymphocytes in schizophrenia. World J. Biol. Psychiatry 8, 30–37.
Yao, J.K., Reddy, R.D., and van Kammen, D.P. (2001). Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15, 287–310.
Youdim, M.B., and Holzbauer, M. (1976). Physiological and pathological changes in tissue monoamine oxidase activity. J. Neural. Transm. 38, 193–229.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Park, C., Park, S.K. Molecular links between mitochondrial dysfunctions and schizophrenia. Mol Cells 33, 105–110 (2012). https://doi.org/10.1007/s10059-012-2284-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10059-012-2284-3